AUPH vs NIO · P/E 28, rev $160.9M vs rev $12.51B
Aurinia Pharmaceuticals Inc (AUPH) versus Nio Inc Class A ADR (NIO) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
Nio Inc Class A ADR (NIO) is a auto manufacturers company listed on US.
Latest reported AUPH revenue for 2026-06-30 was $160.9M. Net income was $71.8M. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Latest reported NIO revenue for 2025-12-31 was $12.51B. Net income was -$2.14B. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. NIO currently screens at market cap $7.61B.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1. NIO currently screens at market cap $7.61B.
Not investment advice. Open the AUPH and NIO stock pages for the full models.
Not investment advice.